随着肾功能的进行性恶化,终末期肾病终末期肾脑患者必须依靠透析治疗维持生命,肾功能减退会使糖和胰岛素代谢以及药物的药代动力学发生显著变化,终末期肾脑的血糖控制变得更为棘手。透析过程中容易出现低血糖,糖尿病及高龄患者在透析过程中更易发生低血糖,同时低血糖的发生还与糖尿病治疗方式以及透析液含糖高低有关。在透析过程中应密切监测血糖,根据血糖波动情况调整降糖方案。 With the progressive deterioration of renal function, end-stage renal disease in patients with end-stage renal disease must rely on dialysis treatment to maintain life, renal dysfunction will make sugar and insulin metabolism and pharmacokinetics of significant changes in end-stage renal blood glucose Control becomes more tricky. Dialysis process prone to hypoglycemia, diabetes and elderly patients more prone to hypoglycemia in the dialysis process, while the incidence of hypoglycemia and diabetes treatment and dialysate sugar level related. In the dialysis process should be closely monitored blood glucose, glycemic adjustment according to the situation of hypoglycemic programs.